Comparative treatment of hyperlipoproteinaemias in chimpanzees.
D000818:Animals; D002784:Cholesterol / Q000097:blood; D002994:Clofibrate; D004036:Diet, Atherogenic; D005227:Fatty Acids / Q000097:blood; D005260:Female; D006949:Hyperlipidemias / Q000188:drug therapy / Q000209:etiology / Q000662:veterinary*; D008074:Lipoproteins / Q000097:blood*; D008075:Lipoproteins, HDL / Q000097:blood; D008077:Lipoproteins, LDL / Q000097:blood; D008079:Lipoproteins, VLDL / Q000097:blood; D008297:Male; D009355:Neomycin / Q000627:therapeutic use; D002679:Pan troglodytes; D010743:Phospholipids / Q000097:blood; D012855:Sitosterols / Q000627:therapeutic use; D013974:Thyroxine / Q000627:therapeutic use; D014280:Triglycerides / Q000097:blood
D005227:Fatty Acids; D008074:Lipoproteins; D008075:Lipoproteins, HDL; D008077:Lipoproteins, LDL; D008079:Lipoproteins, VLDL; D010743:Phospholipids; D012855:Sitosterols; D014280:Triglycerides; D002784:Cholesterol; D002994:Clofibrate; D009355:Neomycin; D013974:Thyroxine